Clearwave Capital’s AbbVie ABBV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$443K Buy
1,694
+24
+1% +$6.15K 0.23% 100
2026
Q2
$420K Sell
1,670
-117
-7% -$25.2K 0.23% 99
2026
Q1
$389K Buy
1,787
+5
+0.3% +$1.11K 0.27% 91
2025
Q4
$407K Buy
+1,782
New +$406K 0.3% 79

Other funds holding ABBV

Clearwave Capital's ABBV Position: Q3 2026 in Review

Clearwave Capital increased its AbbVie (ABBV) stake by 1.4% in Q3 2026, buying an estimated $6.15K and bringing the position to 1,694 shares worth $443K. The position accounts for 0.23% of the portfolio, ranked #100.

Clearwave Capital first reported a position in ABBV in Q4 2025 and has held it in 4 quarters since. 4,279 funds tracked by Wall St. Rank hold ABBV as of Q3 2026.

  • Clearwave Capital held 1,694 shares of AbbVie worth $443K as of Q3 2026.
  • Clearwave Capital bought 24 AbbVie shares in Q3 2026, an estimated $6.15K.
  • AbbVie made up 0.23% of Clearwave Capital's portfolio in Q3 2026, its #100 holding.
  • Clearwave Capital first reported a position in AbbVie in Q4 2025 and has held it in 4 quarters since.
  • 4,279 funds tracked by Wall St. Rank held AbbVie as of Q3 2026.

Based on Clearwave Capital's 13F filing for Q3 2026, filed 27 Oct 2026.